New Jersey City University
About NJUC  Academics  Admissions  Life At NJCU  Athletics  Alumni  Apply On-Line  
LOGO
TB UPDATES
TUBERCULOSIS  (TB)
 

TB UPDATE
 
The Hudson County Chest Clinic (Jersey City) has notified NJCU that a member of our campus community has been treated for active pulmonary Tuberculosis.
The individual is under treatment and is not contagious. The Hudson County Chest Clinic identified a small group of persons on and off campus who are considered previous close contacts of the patient and as such require Mantoux (Tuberculin) Skin Testing. Contacts of the patient were sent registered letters during the week of 10/05/09 notifying them.
For the convenience of our campus contacts of the patient, we have arranged two dates for on-campus tuberculin testing, and two reading dates. In addition, our two NJCU campus nurses have been trained in administering the tuberculin test and will provide the test to anyone named in the contact group. Follow-up will be done to assure the continued health of our community.
Only those persons in prolonged personal contact (in closed or poorly ventilated spaces) with this patient will require testing and have been identified as noted above.
A review of campus spaces was also conducted.
In addition to the contact letters and contact testing, NJCU arranged for an optional information session on Tuesday, October 13th, 2009 (2:00pm) Vodra 101, Conference room D. The following Powerpoint is the exact presentation given at the information session. CLICK HERE TO VIEW A PDF OF THE POWERPOINT PRESENTATION
If you were unable to attend the information session, you are welcome to review the PDF and direct your questions to me, Carolyn Hunter, RN, BC, BSN, Supervisor of the NJCU Health & Wellness Center at Chunter@njcu.edu.
 If I need additional support in answering your question, I will contact Mr. Cortes and obtain your answer. NJCU is fully cooperating with the local health officials and every effort is being made to assure the health of our campus community.
You are also welcome to call the Hudson County Chest Clinic directly with your questions and concerns (201) 915-1042 and ask for Regina Petrinczyk, RN or Mr. Tony Obanye, Field Representative. 


 
TB BASICS:
Tuberculosis (often called TB) is a bacterial infection caused by a germ called Mycobacterium tuberculosis that usually affects the lungs, but can affect other parts of the body.

It is not easy to become infected with tuberculosis. Usually a person has to be close to someone with TB disease for a  very long period of time. TB is usually spread between family members, close friends, and people who work or live together in closed or poorly ventilated spaces over a long period of time.
Even if someone tests positive or becomes infected with tuberculosis, that does not mean they will get TB disease. Most people who become infected do not develop TB disease because their body's defenses protect them. Most active cases of TB disease result from activating old infection in people with impaired immune systems.
 

 
 
Great online resources of information about Tuberculosis:
 
New Jersey State Department of Health:
http://www.state.nj.us/health/cd/tbhome.htm  or
http://www.state.nj.us/health/cd/f_tb.htm
 
Centers for Disease Control (CDC):
http://www.cdc.gov/tb/
 
MedlinePlus:
http://www.nlm.nih.gov/medlineplus/tuberculosis.html
 
Mayo Clinic:
http://www.mayoclinic.com/health/tuberculosis/DS00372
 
 

 
 
TESTING FOR EXPOSURE TO TUBERCULOSIS:
 
What is a TB or Mantoux Test?
 
Tuberculosis Skin Test  (Mantoux or PPD Skin Test)
Excerpted from MedicineNet.com
 
What is the tuberculosis skin test?

The tuberculosis skin test (also known as the tuberculin test , Mantoux, or PPD test) is a test used to determine if someone has developed an immune response to the bacterium that causes tuberculosis (TB).
An incubation period of two to 12 weeks is usually necessary after exposure to the TB bacteria in order for the PPD test to be positive.
 
How is the tuberculosis skin test administered?
 
The standard recommended tuberculin test, known as the Mantoux test, is administered by injecting a 0.1 mL volume containing 5 TU (tuberculin units) PPD. The PPD is injected just beneath the surface of the skin using a very small, thin needle. A discrete, pale elevation of the skin (a wheal) 6 to 10 mm in diameter is produced. This elevation is generally quickly absorbed.  
 
What is the method of reading the tuberculosis skin test?
"Reading" the skin test means detecting a raised area of skin reaction, referred to as induration. Induration is the key item to detect, not redness. Skin tests should be read 48 or 72 hours after the test. Tests read before 48 hours or after 72 hours are not accepted.
 
The diameter of the induration should be measured for a palpable, raised, hardened area around the site of injection. Again, redness is not measured.
A tuberculin reaction is classified as positive based on the diameter of the induration. In a screening test, induration greater than or equal to 15 mm is considered a positive skin test. If you have been a personal contact of someone with active TB, 10 mm of induration is considered a positive skin test.  Induration of less than 2 mm  ( 0-2mm) is considered a negative skin test.

A person who received a BCG vaccine (administered in some countries but not the U.S.) against tuberculosis may also have a positive skin reaction to the TB test, although this is not always the case. The positive reaction that is due to the vaccine may persist for years. Those who were vaccinated after the first year of life or who had more than one dose of the vaccine have the greatest likelihood of having a persistent positive result than those who were vaccinated as infants.
Back To Top
PRINTABLE VIEW
ADD TO FAVORITES
Copyright ©2009 NJCU :: Health and Wellness Center - All Rights Reserved

NJCU DISCLAIMER | CONTACT WEBSITE SUPPORT

New Jersey City University
2039 Kennedy Boulevard Jersey City, New Jersey 07305-1597
Copyright © New Jersey City University All Rights Reserved





Current Website (Home Page)